Current Status of Biomedical Products for Gene and Cell Therapy of Recessive Dystrophic Epidermolysis Bullosa

被引:0
|
作者
Zorina, Alla [1 ,2 ]
Zorin, Vadim [1 ,2 ]
Isaev, Artur [1 ]
Kudlay, Dmitry [3 ,4 ]
Manturova, Natalia [5 ,6 ]
Ustugov, Andrei [5 ,6 ]
Kopnin, Pavel [7 ]
机构
[1] Artgen Biotech, Moscow 119333, Russia
[2] Skincell LLC, Moscow 119333, Russia
[3] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Dept Pharmacol, Moscow 119991, Russia
[4] Lomonosov Moscow State Univ, Dept Pharmacognosy, Ind Pharm, Moscow 119992, Russia
[5] Pirogov Russian Natl Res Med Univ, Dept Plast & Reconstruct Surg Cosmetol & Cell Tech, Moscow 117997, Russia
[6] JSC Plast Surg & Cosmetol Inst, Moscow 125047, Russia
[7] NN Blokhin Natl Med Res Ctr Oncol, Sci Res Inst Carcinogenesis, Moscow 115522, Russia
基金
俄罗斯科学基金会;
关键词
epidermolysis bullosa; skin; treatment; gene and cell therapy; stem cells; gene delivery; study outcomes; MESENCHYMAL STEM-CELLS; BONE-MARROW-TRANSPLANTATION; RETROVIRAL DNA INTEGRATION; UMBILICAL-CORD BLOOD; VII COLLAGEN; STROMAL CELLS; MOUSE MODEL; FIBROBLAST THERAPY; CULTURED SKIN; COL7A1;
D O I
10.3390/ijms251910270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This detailed review describes innovative strategies and current products for gene and cell therapy at different stages of research and development to treat recessive dystrophic epidermolysis bullosa (RDEB) which is associated with the functional deficiency of collagen type VII alpha 1 (C7) caused by defects in the COL7A1 gene. The use of allogenic mesenchymal stem/stromal cells, which can be injected intradermally and intravenously, appears to be the most promising approach in the field of RDEB cell therapy. Injections of genetically modified autologous dermal fibroblasts are also worth mentioning under this framework. The most common methods of RDEB gene therapy are gene replacement using viral vectors and gene editing using programmable nucleases. Ex vivo epidermal transplants (ETs) based on autologous keratinocytes (Ks) have been developed using gene therapy methods; one such ET successively passed phase III clinical trials. Products based on the use of two-layer transplants have also been developed with both types of skin cells producing C7. Gene products have also been developed for local use. To date, significant progress has been achieved in the development of efficient biomedical products to treat RDEB, one of the most severe hereditary diseases.
引用
收藏
页数:29
相关论文
共 50 条
  • [41] Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa
    Cianfarani, Francesca
    Zambruno, Giovanna
    Castiglia, Daniele
    Odorisio, Teresa
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (07) : 1445 - 1453
  • [42] Intradermal Injection of Bone Marrow Mesenchymal Stromal Cells Corrects Recessive Dystrophic Epidermolysis Bullosa in a Xenograft Model
    Ganier, Clarisse
    Titeux, Matthias
    Gaucher, Sonia
    Peltzer, Juliette
    Le Lorc'h, Marc
    Lataillade, Jean-Jacques
    Ishida-Yamamoto, Akemi
    Hovnanian, Alain
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (11) : 2483 - 2486
  • [43] Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects
    Hou, Ping-Chen
    del Agua, Nathalie
    Lwin, Su M.
    Hsu, Chao-Kai
    McGrath, John A.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 455 - 473
  • [44] Recessive dystrophic epidermolysis bullosa.: Report of one case
    Cordero, C
    González, S
    Castillo, C
    Morales, E
    Misad, C
    Ruiz-Esquide, F
    REVISTA MEDICA DE CHILE, 2004, 132 (05) : 614 - 618
  • [45] Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review
    Li, Alvin W.
    Prindaville, Brea
    Bateman, Scot T.
    Gibson, Timothy E.
    Wiss, Karen
    PEDIATRIC DERMATOLOGY, 2017, 34 (06) : 647 - 655
  • [46] Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
    Chamorro, Cristina
    Mencia, Angeles
    Almarza, David
    Duarte, Blanca
    Buening, Hildegard
    Sallach, Jessica
    Hausser, Ingrid
    Del Rio, Marcela
    Larcher, Fernando
    Murillas, Rodolfo
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2016, 5 : 1 - 13
  • [47] Autosomal recessive type of dystrophic epidermolysis bullosa with a novel variant in the COL7A1 gene
    Nikolova, Slavena Enkova
    Kamburova, Zornitsa Bogomilova
    Vasilev, Preslav Plamenov
    Kovacheva, Katya Stefanova
    Yordanova, Ivelina Asparuhova
    BIOMEDICAL REPORTS, 2024, 21 (05)
  • [48] Diagnosis by electron microscopy of recessive dystrophic epidermolysis bullosa.
    Glorio, RR
    Solari, A
    Woscoff, A
    MEDICINA-BUENOS AIRES, 2000, 60 (03) : 354 - 356
  • [49] ORAL INVOLVEMENT OF RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA-INVERSA
    WRIGHT, JT
    FINE, JD
    JOHNSON, LB
    STEINMETZ, TT
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1993, 47 (08): : 1184 - 1188
  • [50] Vitamin and trace metal levels in recessive dystrophic epidermolysis bullosa
    Ingen-Housz-Oro, S
    Blanchet-Bardon, C
    Vrillat, M
    Dubertret, L
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (06) : 649 - 653